Most recent articles
A. S. Rathore, J. G. Stevenson, H. Chhabra and C. Maharana (2021) The Global Landscape on Interchangeability of Biosimilars, Expert Opinion on Biological Therapy; 2021
A. S. Rathore, J. G. Stevenson and H. Chhabra, Considerations related to comparative clinical studies for biosimilars, Expert Opinion on Drug Safety; 2021
A. S. Rathore, N. Saxena, G. Thakur, N. Deore, Challenges in process control for continuous processing for production of monoclonal antibody products, Current Opinion in Chemical Engineering; 31 (2021) 100671
N. Kateja, N. Nitika, R. S. Fadnis and A. S. Rathore, A novel reactor configuration for continuous virus inactivation, Biochemical Engineering Journal; 167 (2021) 107885
S. Joshi, L. R. Khatri, A. Kumar and A. S. Rathore, Monitoring size and oligomeric-state distribution of therapeutic mAbs by NMR and DLS: Trastuzumab as a case study, Journal of Pharmaceutical and Biomedical Analysis; 195 (2021) 113841
G. Thakur, N. Saxena, A. Tiwari and A.S. Rathore, Control of Surge Tanks for Continuous Manufacturing of Monoclonal Antibodies, Biotechnology and Bioengineering; 2021
S. Joshi, S. Kumari and A.S. Rathore, Identification and characterization of carbonylation sites in trastuzumab biosimilars, International Journal of Biological Macromolecules; 169 (2021) 95-102.
S. Nikita, A. Tiwari, D. Sonawat, H. Kodamana and A.S. Rathore, Reinforcement learning based optimization of process chromatography for continuous processing of biopharmaceuticals, Chemical Engineering Science; 230 (2021) 116171.
S. Singh, D. Kumar, H. Malani and A.S. Rathore, LC–MS based case-by-case analysis of the impact of acidic and basic charge variants of bevacizumab on stability and biological activity. Scientific Reports;11 (2021) 2487
S. Mishra, V. Kumar, J. Sarkar and A.S. Rathore, CFD based mass transfer modeling of a single use bioreactor for production of monoclonal antibody biotherapeutics, Chemical Engineering Journal; 412 (2021) 128592.
A.S Rathore and A. Bhargava. Regulatory considerations in biosimilars: Latin America region, Preparative Biochemistry & Biotechnology; 51 (2021) 201-206.
A. Mishra and A.S. Rathore, RNA dependent RNA polymerase (RdRp) as a drug target for SARS-CoV2, Journal of Biomolecular Structure and Dynamics; 2021.
V. Hebbi, G. Thakur and A.S. Rathore, Process analytical technology application for protein PEGylation using near infrared spectroscopy: G-CSF as a case study, Journal of Biotechnology; 325 (2021) 303-311.
A.S. Rathore and A. Bhargava, Regulatory considerations in biosimilars: Asia pacific regions, Preparative Biochemistry & Biotechnology; 51 (2020) 1-8.
A.S. Rathore, H. Chhabra and A. Bhargava, Approval of biosimilars: a review of unsuccessful regulatory filings, Expert Opinion on Biological Therapy; 21 (2020) 19-28.
S. Singh, A. Mishra, G. Goel, N. Chirmule and A.S. Rathore, Modulation of granulocyte colony stimulating factor conformation and receptor binding by methionine oxidation, Proteins: Structure, Function, and Bioinformatics; 89 (2020) 68-80.
A.S. Rathore and R. Bhambure, High-Throughput Process Development: I—Process Chromatography, Methods in Molecular Biology; 2178 (2020) 11-20.
A.S. Rathore and R. Bhambure, Aqueous Two-Phase-Assisted Precipitation of Proteins: A Platform for Isolation of Process-Related Impurities from Therapeutic Proteins, Methods in Molecular Biology; 2178 (2020) 81-91.
N. Swaminathan, P. Priyanka, A.S Rathore, S. Sivaprakasam and S. Subbiah. Multiobjective Optimization for Enhanced Production of Therapeutic Proteins in Escherichia coli: Application of Real-Time Dielectric Spectroscopy, Industrial & Engineering Chemistry Research; 59 (2020) 21841-21853
P. Gupta, N. Kateja, S. Mishra, H. Kaur, A.S. Rathore, Economic assessment of continuous processing for manufacturing of biotherapeutics, Biotechnology Progress; 2020
K. Pandi, A. Chauhan, W. Khan and A.S. Rathore, Phosphate starvation controls lactose metabolism to produce recombinant protein in Escherichia coli, Applied Microbiology and Biotechnology; 104 (2020) 9707-9718.
G. Thakur, S. Thori and A.S. Rathore, Implementing PAT for single-pass tangential flow ultrafiltration for continuous manufacturing of monoclonal antibodies, Journal of Membrane Science; 613 (2020) 118492.
A. Mishra, R. Patil, S. Singh, P. Priyanka and A.S. Rathore, Mechanistic explanation of structural and functional changes induced by methionine mutation in G-CSF protein, Current Research in Biotechnology; 2 (2020) 37-44.
N. Kateja, N. Nitika, S. Dureja and A.S. Rathore, Development of an integrated continuous PEGylation and purification Process for granulocyte colony stimulating factor, Journal of Biotechnology; 322 (2020) 79-89
N. Saxena, P. Gupta, R. Raman and A.S. Rathore, Role of data science in managing COVID-19 pandemic, Indian Chemical Engineer; 62 (2020) 385-395.
S. Singh, D. Kumar and A.S. Rathore, Understanding Oxidation Propensity in GCSF and Assessment of its Safety and Efficacy, Pharmaceutical Research; 37 (2020) 1-14.
V. Amritkar, S. Adat, V. Tejwani, A.S. Rathore and R. Bhambure, Engineering Staphylococcal Protein A for high-throughput affinity purification of monoclonal antibodies, Biotechnology Advances; 44 (2020) 107632.
R. Bansal, R. Dash and A.S. Rathore, Impact of mAb Aggregation on Its Biological Activity: Rituximab as a Case Study, Journal of Pharmaceutical Sciences; 109 (2020) 2684-2698
S. Hadpe, V. Mohite, S. Alva and A.S. Rathore, Pretreatments for enhancing clarification efficiency of depth filtration during production of monoclonal antibody therapeutics, Biotechnology Progress; 36 (2020) e2996
J. Kumar, A. Chauhan, R. Shah, J. Gupta and A.S. Rathore, Amino acid supplementation for enhancing recombinant protein production in E. coli, Biotechnology and Bioengineering;117 (2020) 2420-2433
S. Joshi, C. Maharana and A.S. Rathore, An application of Nano Differential Scanning Fluorimetry for Higher Order Structure assessment between mAb originator and biosimilars: Trastuzumab and Rituximab as case studies, Journal of Pharmaceutical and Biomedical Analysis; 186 (2020) 113270